Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 4 (2019) The health technology assessment system in Australia Abstract  similar documents
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
"... influence the committee decision. In addition to the full reimbursement of pharmaceuticals, the committee ..."
 
Vol 12, No 2 (2019) Health technology assessment and reimbursement of pharmaceuticals in Italy Abstract  similar documents
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
"... ) is the national health technology assessment (HTA) authority in charge of the reimbursement and formulary-listing ..."
 
Vol 13, No 2 (2020) Affordability of in vivo gene therapy. Problems and potential solutions Abstract  similar documents
V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko
"... pharmaceutical market. The analysis of the methodology used in the found CESs was performed based on the given ..."
 
Vol 11, No 2 (2018) Introduction of medical products into healthcare practice and costs reimbursement: European experience Abstract  similar documents
V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii
 
Vol 11, No 3 (2018) What is the role of antineoplastic drug safety in reimbursement decision making? Abstract  similar documents
A. S. Kolbin, A. A. Kurylev
"... to reimbursement in Russia has grown from 15% to 28%. This group of drugs is characterized by severe adverse events ..."
 
Vol 7, No 4 (2014) IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? Abstract  similar documents
V. V. Omelyanovskiy
"... reimbursement) shows a substantial variety and presence of national peculiarities; however the majority ..."
 
Vol 9, No 1 (2016) MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 Abstract  similar documents
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
"... inclusion and exclusion into the reimbursement lists in Russian Federation. The liner mathematical model ..."
 
Vol 8, No 1 (2015) PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION Abstract  similar documents
L. S. Melnikova
"... are used in foreign countries at reimbursement of costs for public drug supply. The author estimates ..."
 
Vol 12, No 2 (2019) Organizational structure and funding of health technology assessment agencies around the world Abstract  similar documents
G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak
"... : «organizational structure of HTA agency», «funding of HTA agency», «pharmaceutical», «reimbursement», «healthcare ..."
 
Vol 10, No 3 (2017) Review of the current approaches to the assessment of the drug innovative potential worldwide Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits
"... significance of a new medical product and make an educated decision on the reimbursement, cost and priority ..."
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov
"... are registered in second-line, however only dasatinib is included in the government drug reimbursement program ..."
 
Vol 11, No 2 (2018) Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations Abstract  similar documents
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov
"... ) in 2018 provides for the reimbursement for hospital stay expenses by the compulsory medical insurance fund ..."
 
Vol 11, No 4 (2018) International experience in determining the cost-effectiveness thresholds Abstract  similar documents
T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky
"... reimbursement. The present review demonstrates that just a few countries (englandandWales,Thailand,Poland,USA ..."
 
Vol 5, No 1 (2012) PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING Abstract  similar documents
M. V. Protsenko, N. I. Koroleva
"... results as a new instrument in pharmaceutical marketing lets marketing specialists know what information ..."
 
Vol 6, No 3 (2013) THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT Abstract  similar documents
N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova
"... The range and sales analysis of pharmaceuticals for the dysmenorrhea treatment on the market ..."
 
Vol 11, No 3 (2018) The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia Abstract  similar documents
V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina
"... the principles of health technologies assessment (HTA) and the reimbursement strategies in Russia have been put ..."
 
Vol 5, No 2 (2012) WORKING OUT OF STRATEGY OF STOREKEEPING OF PHARMACEUTICAL FIRM Abstract  similar documents
A. I. Borodin
"... Research of experience of the firm which is engaged in pharmaceutical business, has confirmed ..."
 
Vol 7, No 2 (2014) THE ANALYSIS OF THE LIPETSK PHARMACEUTICAL MARKET OF NASAL GLUCOCORTICOSTEROID Abstract  similar documents
K. V. Danilova, I. M. Razdorskaya
"... in the present paper we have studied a group of pharmaceutical drugs used in the treatment ..."
 
Vol 7, No 4 (2014) ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva
"... are the representatives of the Ministry of Health, pharmaceutical companies, distributors and pharmacy organizations ..."
 
Vol 5, No 1 (2012) UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES Abstract  similar documents
A. Y. Kulikov, A. G. Voskanyan
"... The article covers the key issues of local pharmaceutical production and ensuring of equitable ..."
 
Vol 10, No 4 (2017) THE INTERNATIONAL PRACTICE OF DRUG SUPPLY IN THE OUTPATIENT SEGMENT Abstract  similar documents
D. V. Lukyantseva, L. S. Mel’nikova, A. P. Tatarinov
 
Vol 12, No 2 (2019) Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available Abstract  similar documents
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev
"... names (INN) of anticancer drugs, whose generics or biosimilars entered the Russian pharmaceutical market ..."
 
Vol 13, No 2 (2020) Biological effects of phytoestrogens: clinical effectiveness and potential application in the treatment of climacteric syndrome Abstract  similar documents
M. A. Chernyavskaya, I. A. Narkevich
 
Vol 7, No 3 (2014) ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... of the official request of the Expert Board on Healthcare of the Council of the Federation Committee on Social ..."
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov
"... tamsulosin and solifenacin therapy, including 35,400 patients eligible for government reimbursement. Using ..."
 
Vol 13, No 2 (2020) Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union Abstract  similar documents
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich
"... of pharmaceutical drugs in the Eurasian Economic Community counties (EAEC). Materials and Methods. The comparison ..."
 
Vol 9, No 3 (2016) MONITORING OF CONSUMER ATTITUDES TO MEDICINES Abstract  similar documents
N. B. Dremova, N. P. Yaroshenko, N. I. Afanaseva, S. V. Solomka
"... . Six of these qualities characterize the pharmaceutical features and merchandising options are seven ..."
 
Vol 8, No 3 (2015) RESEARCH EXCELLENCE INDEX AS INSTRUMENT OF PERFORMANCE-ORIENTED BUDGETING Abstract  similar documents
O. V. Bogacheva, V. E. Grigorov
"... экспертного суждения. Опыт ряда стран, прежде всего, Великобритании, Австралии и Новой Зеландии ..."
 
Vol 9, No 3 (2016) METHOD «COST-EFFECTIVENESS» IN EVALUETION OF ATIBIOTIC TREATMENT OF ACYTR OBSTRUCTIVE BRONCHITIS IN CHILDREN IN HOSPITAL Abstract  similar documents
O. V. Zhukova, S. V. Kononova
"... obstructive bronchitis in children. The original drug Augmentin (Smithkline Beecham Pharmaceuticals ..."
 
Vol 12, No 2 (2019) Recent changes in the pharmacovigilance system in the Russian Federation and the EAEU Abstract  similar documents
G. N. Gildeeva, A. V. Belostotsky
"... countries in order to adopt the strategy of the pharmaceutical industry players. Materials and methods ..."
 
Vol 9, No 1 (2016) REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES Abstract  similar documents
K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... to expenditure growth have focused on outpatient pharmaceuticals, evaluation of medical technologies and reducing ..."
 
Vol 12, No 2 (2019) Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava
"... characteristics of ω -3 PUFAs pharmaceutical forms and the modern statistical analysis of biomedical data ..."
 
Vol 12, No 4 (2019) Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation Abstract  similar documents
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev
"... to the level identified in a previous retrospective analysis of the pharmaceutical market. The baseline ..."
 
Vol 12, No 4 (2019) Crucial areas of the economic analysis of public cancer care Abstract  similar documents
D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova
"... cancer care programs and provide a wide range of medical and pharmaceutical services to the public. Aim ..."
 
1 - 34 of 34 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)